News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Matteo Lambertini: Extremely honored and grateful for the chance to contribute to this important ASCO research statement on why and how to measure ovarian toxicity in clinical trials.
Photo taken from Matteo Lambertini/Twitter
Oct 7, 2023, 19:20

Matteo Lambertini: Extremely honored and grateful for the chance to contribute to this important ASCO research statement on why and how to measure ovarian toxicity in clinical trials.

Matteo Lambertini, Associate Professor at University of Genova, shared on Twitter:

“Extremely honored and grateful for the chance to contribute to this important ASCO research statement on why and how to measure ovarian toxicity in clinical trials: really hope this work can help improving the care of young women with cancer.”

Matteo Lambertini: Extremely honored and grateful for the chance to contribute to this important ASCO research statement on why and how to measure ovarian toxicity in clinical trials.

For the article click here.
Source: Matteo Lambertini/Twitter

ASCO cancer Matteo Lambertini OncoDaily Oncology
Special Coverage
Societies
Sep 6, 2025, 14:50
Duke Radiation Oncology Is Recruiting for Radiation Oncology Research Scholar Position
Voices
Sep 6, 2025, 14:40
Why Multi-Cancer Early Detection Tests Hold So Much Promise - ACS CAN
Voices
Sep 6, 2025, 14:27
The Jimmy Fund: Walking Together Against Cancer
Voices
Sep 6, 2025, 14:22
Only 2 Days Left for Our Childhood Cancer Awareness Month Auction - World Child Cancer
Career Updates
Sep 6, 2025, 14:18
TOGA Welcomes Emily Stone as the New Chair of the Board of Directors
Voices
Sep 6, 2025, 14:16
Share Your Research with the Paediatric Oncology Community at SIOP Africa 2026!
Oncolibrary
Sep 6, 2025, 14:11
How AI in Skin Cancer Detection Is Changing Care for Patients
Voices
Sep 6, 2025, 14:10
Alireza Mansouri: Curasight Launches Phase 1 uTREAT Trial for Glioblastoma
Voices
Sep 6, 2025, 13:52
Shane Jacobson: How Impactful Research Powers National and Global Advancements in Cancer Care
Voices
Sep 6, 2025, 13:50
Devika Das: When Thoracic Oncologist Is in Orientation With an Excellent Thoracic Surgeon
Voices
Sep 6, 2025, 13:46
Timothy Rebbeck: Encouraging NIH Funding Update
Voices
Sep 6, 2025, 13:45
Bishal Gyawali: The 2025 WHO EML List is Just Out